Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 4”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Early research (Phase 1)Study completedNCT00979316
What this trial is testing

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 62
Early research (Phase 1)Looking for participantsNCT03878121
What this trial is testing

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

Who this might be right for
Healthy Volunteer
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Ended earlyNCT00602680
What this trial is testing

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sanofi 1
Early research (Phase 1)Study completedNCT05532358
What this trial is testing

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Who this might be right for
Healthy Volunteers
MODAG GmbH 54
Early research (Phase 1)Study completedNCT01989533
What this trial is testing

Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers

Who this might be right for
Vaccine Response
National Institute of Allergy and Infectious Diseases (NIAID) 62
Early research (Phase 1)Study completedNCT03408262
What this trial is testing

Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women

Who this might be right for
Human Immunodeficiency Virus
Imperial College London 68
Testing effectiveness (Phase 2)Study completedNCT00948259
What this trial is testing

Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Noscira SA 30
Testing effectiveness (Phase 2)Ended earlyNCT00582855
What this trial is testing

Effect of AQW051 in Patients With Memory Impairment

Who this might be right for
Mild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Novartis Pharmaceuticals 54
Testing effectiveness (Phase 2)Study completedNCT01350362
What this trial is testing

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Noscira SA 306
Large-scale testing (Phase 3)Ended earlyNCT00667810
What this trial is testing

Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients

Who this might be right for
Alzheimer Disease
Pfizer 901
Not applicableUnknownNCT02835716
What this trial is testing

Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO

Who this might be right for
Alzheimer Disease
Millennium Magnetic Technologies, LLC 150
Testing effectiveness (Phase 2)Study completedNCT03461861
What this trial is testing

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

Who this might be right for
APOE 4
Medical College of Wisconsin 26
Early research (Phase 1)Study completedNCT01443936
What this trial is testing

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 96
Large-scale testing (Phase 3)Study completedNCT04770220
What this trial is testing

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Who this might be right for
Early Alzheimer's Disease
Alzheon Inc. 325
Testing effectiveness (Phase 2)Ended earlyNCT01626391
What this trial is testing

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 9
Early research (Phase 1)Looking for participantsNCT06372821
What this trial is testing

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Who this might be right for
Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London 10
Early research (Phase 1)Study completedNCT01006798
What this trial is testing

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Who this might be right for
Bird FluInfluenza
Emergent BioSolutions 166
Early research (Phase 1)Study completedNCT00519298
What this trial is testing

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Who this might be right for
HealthyAdult
Wyeth is now a wholly owned subsidiary of Pfizer 25
Early research (Phase 1)Ended earlyNCT01137799
What this trial is testing

The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

Who this might be right for
SchizophreniaAlzheimer's DiseaseCognition Disorders
Janssen Pharmaceutica N.V., Belgium 47
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Load More Results